HonorHealth Research Institute treats first patient in global trial targeting aggressive melanoma
HonorHealth Research Institute recently treated the first patient in a 50-site international clinical trial that will test a new type of therapy aimed at difficult-to-treat melanoma, an aggressive type of skin cancer.
news-medical.net/news/20250429/HonorHealth-Research-Institute-treats-first-patient-in-global-trial-targeting-aggressive-melanoma.aspx
---
@Genica_NEWS
MD Anderson researchers present promising clinical trial results at AACR 2025
Researchers from The University of Texas MD Anderson Cancer Center will present promising results from clinical trials in three minisymposia abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2025.
news-medical.net/news/20250426/MD-Anderson-researchers-present-promising-clinical-trial-results-at-AACR-2025.aspx
---
@Genica_NEWS
Breakthrough DNA editing in Lactobacillus offers safer probiotics
A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.
news-medical.net/news/20250424/Breakthrough-DNA-editing-in-Lactobacillus-offers-safer-probiotics.aspx
---
@Genica_NEWS
H5N1's evolutionary leap could undermine vaccines and heighten human infection risk
From egg prices to pet food recalls – and now, confirmation that another strain of bird flu has infected a large commercial flock of broiler chickens on a Mississippi farm – headlines are capturing escalating concern over H5N1's spread.
news-medical.net/news/20250424/H5N1s-evolutionary-leap-could-undermine-vaccines-and-heighten-human-infection-risk.aspx
---
@Genica_NEWS
New approach targets cell surface protein to treat leukemia and solid tumors
In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.
news-medical.net/news/20250423/New-approach-targets-cell-surface-protein-to-treat-leukemia-and-solid-tumors.aspx
---
@Genica_NEWS
Dr. Jeremie Poschmann's data-driven approach to immunology and translational science
In a wide-ranging Genomic Press Interview, Dr. Jeremie Poschmann of INSERM and Université de Nantes shares the story behind his bold, data-centric approach to immunology and translational science.
news-medical.net/news/20250422/Dr-Jeremie-Poschmanns-data-driven-approach-to-immunology-and-translational-science.aspx
---
@Genica_NEWS
Scientists track liquid to solid shift in brain disease proteins
An international research collaboration led by Rutgers University-New Brunswick scientists that examined microscopic blobs of protein found in human cells has discovered that some morph from an almost honey-like substance to a hard candy-like solid.
news-medical.net/news/20250418/Scientists-track-liquid-to-solid-shift-in-brain-disease-proteins.aspx
---
@Genica_NEWS
CellVoyant's AI-Powered Vision for the Future of Cell Therapy
CellVoyant leverages AI and live-cell imaging to predict cellular behavior, transforming cell therapy development and making it more accessible and efficient.
news-medical.net/news/20250416/CellVoyants-AI-Powered-Vision-for-the-Future-of-Cell-Therapy.aspx
---
@Genica_NEWS
Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China
Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has signed an exclusive distribution agreement with MineBio, a leading Chinese supply chain and logistics organization
news-medical.net/news/20250416/Atelerix-signs-exclusive-agreement-with-MineBio-to-establish-distribution-channel-for-non-cryogenic-cell-preservation-solutions-in-China.aspx
---
@Genica_NEWS
Study offers a potential new strategy to improve treatment responses in multiple myeloma patients
Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment responses in multiple myeloma patients by blocking a protein that plays a key role in drug resistance.
news-medical.net/news/20250415/Study-offers-a-potential-new-strategy-to-improve-treatment-responses-in-multiple-myeloma-patients.aspx
---
@Genica_NEWS
Bacteria engineered for remote sensing through color signatures
Bacteria can be engineered to sense a variety of molecules, such as pollutants or soil nutrients. In most cases, however, these signals can only be detected by looking at the cells under a microscope or similarly sensitive lab equipment, making them impractical for large-scale use.
news-medical.net/news/20250411/Bacteria-engineered-for-remote-sensing-through-color-signatures.aspx
---
@Genica_NEWS
A dual perspective: Employer and employee views on obesity management
A new study aimed at understanding perceptions of obesity management and the use of anti-obesity medicine by employers and employees in the US has been published in the peer-reviewed journal Population Health Management.
news-medical.net/news/20250410/A-dual-perspective-Employer-and-employee-views-on-obesity-management.aspx
---
@Genica_NEWS
MSC-derived extracellular vesicles show promise in treating high-dose radiation injuries
A new study in the peer-reviewed journal Stem Cells and Development highlights the potential of mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) as a therapeutic strategy for high-dose radiation injuries by promoting hematopoietic recovery and improving survival.
news-medical.net/news/20250409/MSC-derived-extracellular-vesicles-show-promise-in-treating-high-dose-radiation-injuries.aspx
---
@Genica_NEWS
New molecular target identified for pancreatic cancer treatment
Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology study published today.
news-medical.net/news/20250408/New-molecular-target-identified-for-pancreatic-cancer-treatment.aspx
---
@Genica_NEWS
Blood test breakthrough pinpoints 70 proteins linked to asthma risk in major genetic study
Researchers used UK Biobank data to identify 70 proteins with genetically predicted roles in asthma, offering insights into disease mechanisms.
news-medical.net/news/20250407/Blood-test-breakthrough-pinpoints-70-proteins-linked-to-asthma-risk-in-major-genetic-study.aspx
---
@Genica_NEWS
Innovative CAR-T cell therapy achieves remarkable results in patients with refractory CD30+ lymphoma
Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep Carreras Leukaemia Research Institute, have developed an innovative CAR-T cell therapy targeting the CD30 protein (HSP-CAR30), which has shown high efficacy in patients with refractory CD30+ lymphoma.
news-medical.net/news/20250429/Innovative-CAR-T-cell-therapy-achieves-remarkable-results-in-patients-with-refractory-CD302b-lymphoma.aspx
---
@Genica_NEWS
Weill Cornell Medicine leads effort to catalog the normal human virome
A major new effort at Weill Cornell Medicine seeks to catalog the normal human virome, the immense ecosystem of viruses that lives in and on us.
news-medical.net/news/20250425/Weill-Cornell-Medicine-leads-effort-to-catalog-the-normal-human-virome.aspx
---
@Genica_NEWS
AI tools improve detection of key immune structures in melanoma
Researchers from the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) have applied AI-driven processes for detecting tertiary lymphoid structures (TLS) in thousands of digital images of melanoma tumor tissue, significantly enhancing TLS identification and survival predictions for operable stage III/IV patients.
news-medical.net/news/20250424/AI-tools-improve-detection-of-key-immune-structures-in-melanoma.aspx
---
@Genica_NEWS
Enjoy our content? Advertise on this channel and reach a highly engaged audience! 👉🏻
It's easy with Telega.io. As the leading platform for native ads and integrations on Telegram, it provides user-friendly and efficient tools for quick and automated ad launches.
⚡️ Place your ad here in three simple steps:
1 Sign up
2 Top up the balance in a convenient way
3 Create your advertising post
If your ad aligns with our content, we’ll gladly publish it.
Start your promotion journey now!
New biomarkers identified for early detection of gynecological cancer
Researchers from the University of Skövde, the University of Gothenburg, and the Sahlgrenska Academy have significantly advanced early detection of gynecological cancer.
news-medical.net/news/20250423/New-biomarkers-identified-for-early-detection-of-gynecological-cancer.aspx
---
@Genica_NEWS
Exploring citrullination as a key regulator of gene expression and disease
Citrullination, a transformative protein post-translational modification, is gaining recognition for its wide-ranging impact on cellular function and human disease.
news-medical.net/news/20250420/Exploring-citrullination-as-a-key-regulator-of-gene-expression-and-disease.aspx
---
@Genica_NEWS
New tool simplifies genomic research and boosts medical breakthroughs
A University of Virginia School of Medicine scientist and collaborators have developed a much-needed new tool to increase the efficiency of genomic research and accelerate the development of new ways to improve human health.
news-medical.net/news/20250416/New-tool-simplifies-genomic-research-and-boosts-medical-breakthroughs.aspx
---
@Genica_NEWS
New enzyme family enables targeted cuts in single-stranded DNA
An INRS team discovers a new family of enzymes capable of inducing targeted cuts in single-stranded DNA .
news-medical.net/news/20250416/New-enzyme-family-enables-targeted-cuts-in-single-stranded-DNA.aspx
---
@Genica_NEWS
Nuclera expands eProtein Discovery capabilities to enable membrane protein production
Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the addition of a new membrane protein workflow to its system.
news-medical.net/news/20250416/Nuclera-expands-eProtein-Discovery-capabilities-to-enable-membrane-protein-production.aspx
---
@Genica_NEWS
MGI tech celebrates 10 years of DNBSEQ™ technology: driving genomics forward with speed, scale, and accessibility
MGI's DNBSEQ™ technology redefines genomics, delivering exceptional sequencing performance and enabling multi-omics applications for diverse scientific fields.
news-medical.net/news/20250415/MGI-tech-celebrates-10-years-of-DNBSEQe284a2-technology-driving-genomics-forward-with-speed-scale-and-accessibility.aspx
---
@Genica_NEWS
Researcher develops biodegradable sanitary pads using water hyacinth
In a casual conversation, researcher Pooja Singh and two of her colleagues were discussing the idea of developing biodegradable sanitary pads and started to contemplate what raw materials to use.
news-medical.net/news/20250411/Researcher-develops-biodegradable-sanitary-pads-using-water-hyacinth.aspx
---
@Genica_NEWS
WPI researcher receives NSF CAREER Award to create bioadhesives for medical applications
A Worcester Polytechnic Institute (WPI) researcher is developing a new class of medical adhesives by bringing together hydrogels and glue-like polymers to safely and reliably connect human tissues to therapeutic devices implanted in the body, such as pacemakers, insulin pumps, and artificial joints.
news-medical.net/news/20250409/WPI-researcher-receives-NSF-CAREER-Award-to-create-bioadhesives-for-medical-applications.aspx
---
@Genica_NEWS
Tulane researchers develop portable device for rapid TB diagnosis
Tulane University researchers have developed a first-of-its-kind handheld diagnostic device that can deliver rapid, accurate tuberculosis diagnoses in under an hour, according to a study published in Science Translational Medicine.
news-medical.net/news/20250409/Tulane-researchers-develop-portable-device-for-rapid-TB-diagnosis.aspx
---
@Genica_NEWS
AI model enhances detection of antibiotic resistance in deadly bacteria
Drug-resistant infections - especially from deadly bacteria like tuberculosis and staph - are a growing global health crisis.
news-medical.net/news/20250407/AI-model-enhances-detection-of-antibiotic-resistance-in-deadly-bacteria.aspx
---
@Genica_NEWS
Scientists engineer promising vaccine target for Lyme disease
Meeting the unmet need for a vaccine is the top priority for researchers studying Lyme disease, which infects about 476,000 people in the U.S. each year and can come with severe complications such as ongoing fatigue and joint issues.
news-medical.net/news/20250407/Scientists-engineer-promising-vaccine-target-for-Lyme-disease.aspx
---
@Genica_NEWS
